nedocromil has been researched along with Cardiac Remodeling, Ventricular in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Janicki, JS; Jubair, S; Li, J | 1 |
Janicki, JS; Levick, SP; Lu, H; Meléndez, GC | 1 |
Brower, GL; Janicki, JS | 1 |
3 other study(ies) available for nedocromil and Cardiac Remodeling, Ventricular
Article | Year |
---|---|
Estrogen inhibits mast cell chymase release to prevent pressure overload-induced adverse cardiac remodeling.
Topics: Animals; Cardiomyopathy, Hypertrophic; Cell Degranulation; Cell Size; Chymases; Collagen; Estradiol; Estrogen Replacement Therapy; Female; Hypertrophy, Left Ventricular; Mast Cells; Myocardium; Myocytes, Cardiac; Nedocromil; Oligopeptides; Organ Size; Ovariectomy; Random Allocation; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta1; Ventricular Dysfunction, Left; Ventricular Remodeling | 2015 |
Prevention of adverse cardiac remodeling to volume overload in female rats is the result of an estrogen-altered mast cell phenotype.
Topics: Animals; Anti-Inflammatory Agents; Cardiomegaly; Collagen; Endothelin-1; Estrogens; Female; Heart Failure; Mast Cells; Nedocromil; Ovariectomy; Phenotype; Rats; Rats, Sprague-Dawley; Stem Cell Factor; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2012 |
Pharmacologic inhibition of mast cell degranulation prevents left ventricular remodeling induced by chronic volume overload in rats.
Topics: Animals; Anti-Inflammatory Agents; Cell Degranulation; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Failure; Heart Ventricles; Hypertrophy, Left Ventricular; Male; Mast Cells; Myocardial Contraction; Nedocromil; Organ Size; Rats; Rats, Sprague-Dawley; Stroke Volume; Vasodilation; Ventricular Function, Left; Ventricular Pressure; Ventricular Remodeling | 2005 |